Sudarshan Pharma Industries Ltd

AI
Sudarshan Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Sudarshan Pharma Industries Ltd

₹ 31.2 -4.05%
23 Oct - close price
sudarshanpharma.com BSE - SME: 543828
About

Incorporated in 2008, Sudarshan Pharma Industries Ltd manufactures API and Pharmaceutical Items. It also trades in Chemicals and Solvents[1]

Key Points

Business Overview:[1][2]
SPIL does jobwork manufacturing in pharmaceutical Items and trading in chemicals and solvents in India. It
specializes in a host of products from rock chemicals intermediates and API to finish formulations and fully
integrated pharmaceutical and chemicals

Website BSE
  • Market Cap ₹ 780 Cr.
  • Current Price ₹ 31.2
  • High / Low ₹ 42.8 / 18.5
  • Stock P/E 32.1
  • Book Value ₹ 6.35
  • Dividend Yield 0.00 %
  • ROCE 14.3 %
  • ROE 14.6 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has delivered good profit growth of 50.6% CAGR over last 5 years
  • Company's working capital requirements have reduced from 42.3 days to 18.9 days

Cons

  • Stock is trading at 4.92 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -1.12%
  • Company has a low return on equity of 13.0% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
101.72 123.62 115.58 161.57 142.31 167.01 158.37 199.81 165.66
99.75 111.21 107.61 146.36 132.03 157.40 147.60 181.51 149.39
Operating Profit 1.97 12.41 7.97 15.21 10.28 9.61 10.77 18.30 16.27
OPM % 1.94% 10.04% 6.90% 9.41% 7.22% 5.75% 6.80% 9.16% 9.82%
0.92 -0.58 0.57 -0.74 1.41 2.09 1.69 3.21 1.35
Interest 3.77 3.96 4.05 4.44 5.71 6.07 6.24 7.27 8.19
Depreciation 0.64 0.65 0.66 0.76 0.79 0.81 0.81 1.00 1.29
Profit before tax -1.52 7.22 3.83 9.27 5.19 4.82 5.41 13.24 8.14
Tax % -22.37% 25.07% 28.20% 24.27% 28.13% 8.92% 20.52% 27.87% 25.80%
-1.18 5.42 2.76 7.03 3.73 4.40 4.31 9.54 6.04
EPS in Rs -0.05 0.23 0.11 0.29 0.15 0.18 0.18 0.40 0.24
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
55 88 139 148 193 357 461 466 502 668 691
55 87 135 143 186 346 446 443 465 619 636
Operating Profit 1 1 4 5 7 11 15 23 38 49 55
OPM % 1.1% 0.8% 3.1% 3.2% 3.8% 3.1% 3.2% 4.9% 7% 7% 8%
0 2 1 0 0 0 1 3 0 8 8
Interest 0 1 2 3 3 3 5 9 16 25 28
Depreciation 0 0 0 0 1 1 1 1 3 3 4
Profit before tax 0 1 3 2 4 7 10 15 19 29 32
Tax % 40% 24% 28% 26% 25% 26% 26% 25% 25% 23%
0 1 2 1 3 5 7 11 14 22 24
EPS in Rs 0.03 0.06 0.16 0.09 0.19 0.36 0.29 0.47 0.58 0.91 1.00
Dividend Payout % 0% 0% 0% 0% 0% 0% 10% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 28%
3 Years: 13%
TTM: 27%
Compounded Profit Growth
10 Years: %
5 Years: 51%
3 Years: 42%
TTM: 16%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 61%
1 Year: 30%
Return on Equity
10 Years: 13%
5 Years: 13%
3 Years: 13%
Last Year: 15%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 2 5 10 10 10 10 24 24 24 24
Reserves 1 4 9 10 13 20 77 88 107 129
6 10 14 21 30 31 34 107 177 282
11 12 17 18 47 77 97 66 96 159
Total Liabilities 20 31 50 58 99 138 232 285 403 594
0 0 2 6 6 6 20 21 42 94
CWIP 0 0 2 0 0 1 0 2 23 3
Investments 0 0 0 0 0 0 12 17 5 8
20 31 47 53 93 130 200 245 334 489
Total Assets 20 31 50 58 99 138 232 285 403 594

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-2 -0 -1 1 3 -4 -29 10 -33 -3
-0 -0 -4 -3 -1 -2 -26 -9 -20 -80
2 -1 8 -0 -2 4 66 -12 54 82
Net Cash Flow 0 -1 3 -2 -0 -1 11 -12 0 -0
Free Cash Flow -2 -0 -5 -4 2 -5 -43 8 -54 -52
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -244% 36% -2% 20% 51% -18% -179% 52% -81% 6%

Ratios

Standalone / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 92 71 68 66 114 75 64 96 110 109
Inventory Days 23 28 29 46 49 51 63 73 114 128
Days Payable 75 49 45 40 90 80 78 52 73 91
Cash Conversion Cycle 40 51 52 72 73 46 50 117 151 146
Working Capital Days 42 52 27 35 29 27 54 60 48 19
ROCE % 16% 20% 12% 15% 19% 15% 14% 14% 14%

Insights

In beta
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Export Revenue as % of Total Revenue
%

Log in to view insights

Please log in to see hidden values.

Login
Number of Exporting Countries
count
Number of Subsidiaries
count
Creditor Days
days
Net Working Capital Days
days
Manufacturing Revenue as % of Total Revenue
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
57.39% 57.39% 57.39% 57.39% 57.39% 57.39% 57.39% 57.39% 57.39% 58.93% 57.81%
3.58% 1.40% 1.40% 13.07% 18.45% 19.49% 20.79% 19.78% 19.95% 19.38% 21.94%
0.00% 0.00% 0.00% 0.00% 0.00% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05%
39.02% 41.20% 41.21% 29.54% 24.16% 23.07% 21.76% 22.79% 22.61% 21.65% 20.19%
No. of Shareholders 1,2449839137871,2121,3271,3831,4071,3461,2311,250

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls

  • Aug 2026
    Transcript
    AI Summary
    PPT
  • Aug 2026
    Transcript
    AI Summary
    PPT
  • May 2026
    Transcript
    AI Summary
    PPT
  • Jan 2026
    Transcript
    AI Summary
    PPT
  • Aug 2025
    Transcript
    AI Summary
    PPT
  • May 2025
    Transcript
    AI Summary
    PPT
  • Jan 2025
    Transcript
    AI Summary
    PPT
  • Jul 2024
    Transcript
    AI Summary
    PPT
  • Jan 2024
    Transcript
    AI Summary
    PPT
  • Sep 2023
    Transcript
    AI Summary
    PPT